UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States

Annals of the American Thoracic Society, 2016-06, Vol.13 (6), p.803-810

2016

Volltextzugriff (PDF)

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow

Canadian respiratory journal, 2024, Vol.2024, p.8034923-8

2024

Volltextzugriff (PDF)

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler

Pulmonary therapy, 2020-12, Vol.6 (2), p.289-301

2020

Volltextzugriff (PDF)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device

Pulmonary medicine, 2021, Vol.2021, p.8881895-7

2021

Volltextzugriff (PDF)

Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?

Life (Basel, Switzerland), 2021-11, Vol.11 (11), p.1270

2021

Volltextzugriff (PDF)

Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers

Journal of aerosol medicine and pulmonary drug delivery, 2017-12, Vol.30 (6), p.381-387

2017

Volltextzugriff (PDF)

Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease

Current opinion in pulmonary medicine, 2024-03, Vol.30 (2), p.174-178

2024

Volltextzugriff (PDF)

Changing Pattern in Malignant Mesothelioma Survival

Translational oncology, 2015-02, Vol.8 (1), p.35-39

2015

Volltextzugriff (PDF)

Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions

Annals of the American Thoracic Society, 2017-08, Vol.14 (8), p.1305-1311

2017

Volltextzugriff (PDF)

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2020-08, Vol.202 (4), p.e74-e87

2020

Volltextzugriff (PDF)

Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions: A Negative Study That Has Positive Implications

Annals of the American Thoracic Society, 2017-05, Vol.14 (5), p.617-618

Ohar, Jill A

2017

Volltextzugriff (PDF)

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer

Cancer research (Chicago, Ill.), 2016-01, Vol.76 (2), p.206-215

2016

Volltextzugriff (PDF)

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?

Drugs (New York, N.Y.), 2012-01, Vol.72 (3), p.301-308

2012

Volltextzugriff (PDF)

Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors

Human molecular genetics, 2021-08, Vol.30 (18), p.1750-1761

2021

Volltextzugriff (PDF)

Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers

Respiratory research, 2009-03, Vol.10 (1), p.21-21, Article 21

2009

Volltextzugriff (PDF)

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction

Cancer letters, 2015-12, Vol.369 (2), p.261-265

2015

Volltextzugriff (PDF)

Risks May Not Be Reasons for COPD Readmissions

Annals of the American Thoracic Society, 2015-09, Vol.12 (9), p.1259-1260

Ohar, Jill A

2015

Volltextzugriff (PDF)

The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review

Chronic obstructive pulmonary diseases, 2019-10, Vol.6 (4), p.341-349

2019

Volltextzugriff (PDF)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important

American journal of respiratory and critical care medicine, 2020-11, Vol.202 (10), p.1482-1482

2020

Volltextzugriff (PDF)

Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers

Chest, 2020-10, Vol.158 (4), p.1413-1419

2020

Volltextzugriff (PDF)

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

International journal of chronic obstructive pulmonary disease, 2019-03, Vol.14, p.585-595

2019

Volltextzugriff (PDF)

Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease

Respiratory medicine, 2023-03, Vol.208, p.107123-107123, Article 107123

2023

Volltextzugriff (PDF)

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1409-1416

2015

Volltextzugriff (PDF)

Nebulized arformoterol: what is its place in the management of COPD?

Therapeutic Advances in Respiratory Disease, 2013-04, Vol.7 (2), p.81-86

2013

Volltextzugriff (PDF)

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

International journal of chronic obstructive pulmonary disease, 2016, Vol.11 (1), p.785-797

2016

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(120)

Sprache

Englisch
(120)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(88)
Science & Technology
(88)
Humans
(64)
Respiratory System
(61)
Female
(40)
Male
(37)
Middle Aged
(34)
Chronic Obstructive Pulmonary Disease
(33)
Aged
(30)
General & Internal Medicine
(29)
Copd
(24)
Adult
(22)
Biological And Medical Sciences
(21)
Critical Care Medicine
(21)
Medical Sciences
(21)
Pulmonary Disease, Chronic Obstructive - Physiopathology
(18)
Original Research
(16)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(15)
Administration, Inhalation
(13)
Risk Factors
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device

Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?

Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers

Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease

Changing Pattern in Malignant Mesothelioma Survival

Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions: A Negative Study That Has Positive Implications

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?

Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors

Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction

Risks May Not Be Reasons for COPD Readmissions

The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important

Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

Nebulized arformoterol: what is its place in the management of COPD?

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

Suchergebnisse filtern